When you're diagnosed with mesothelioma, every decision matters. But here's something most doctors won't tell you in the initial consultation: where you get treatment could be the difference between months and years of life. National studies prove that patients at top cancer centers don't just live longer — they also suffer fewer complications and gain access to treatments that simply aren't available anywhere else.
Most people diagnosed with mesothelioma are referred to the nearest hospital. As the research shows, that can be a costly mistake. And because asbestos exposure creates legal rights that can fund the care you need, the gap between what's nearby and what's best doesn't have to define your outcome.
The Research Is Clear: Better Hospitals Save Lives
Two major national studies examined thousands of mesothelioma patients across the country. What they found should change how every patient thinks about their first referral.
The Survival Gap Is Real and It's Measured in Years
Researchers studying 2,682 mesothelioma patients nationwide concluded: "We demonstrate better survival outcomes for malignant peritoneal mesothelioma treated at academic compared to community facilities."
A second major analysis of pleural mesothelioma patients reached a parallel conclusion, finding that patients treated at high-volume facilities experienced significantly more favorable postoperative outcomes, with implications for patient counseling, referring providers, and long-term cost-effectiveness.
The numbers tell a stark story:
Outcome Measure | High-Volume / Academic Centers | Community Centers |
|---|---|---|
Peritoneal mesothelioma — median survival | 24.8 months | 11.6 months |
Pleural mesothelioma — 90-day mortality | 10.0% | 14.6% |
Peritoneal mesothelioma — 5-year survival | 29.7% | 18.3% |
Access to HIPEC treatment | 28.8% | 10.4% |
30-day readmission rates | 4.6% | 6.1% |
Patients at academic hospitals lived more than twice as long for peritoneal mesothelioma. That's a difference of over a year with family and loved ones. For pleural mesothelioma, nearly 5 out of every 100 patients who would have died at a low-volume hospital survived when treated at a high-volume center.
Why Most Hospitals Aren't Enough
The average hospital sees one or two mesothelioma cases per year, and many see none at all. That limited volume means they often cannot offer:
Advanced surgical procedures like cytoreductive surgery with HIPEC for peritoneal mesothelioma. This complex operation removes all visible tumor from the abdominal cavity and bathes it with heated chemotherapy to eliminate remaining cancer cells. Studies show it can extend survival from less than a year to three or more years for eligible patients, but it requires specialized training and equipment that most hospitals don't have.
Lung-sparing or lung-removing surgery for pleural cases, including pleurectomy/decortication and extrapleural pneumonectomy. These procedures require thoracic surgeons with extensive mesothelioma experience. The difference between a surgeon who performs these regularly and one who rarely does can mean the difference between recovery and life-threatening complications.
The latest immunotherapy combinations, including the FDA-approved nivolumab + ipilimumab regimen, which extends survival in aggressive subtypes by helping the immune system recognize and attack mesothelioma cells. Many community hospitals lack the expertise to administer these treatments or manage their distinctive side effects.
Clinical trial access, which often provides the only pathway to breakthrough therapies before they're widely available. Most active trials are concentrated at major academic centers with research programs.
Multidisciplinary care teams — surgical oncologists, medical oncologists, radiation specialists, and pathologists who meet regularly around a single patient's case. For a rare and complex cancer, that level of coordination produces meaningfully better outcomes.
The treatment gap this creates is documented in the research: academic facilities performed major surgery on 42.9% of their peritoneal patients; community facilities performed it on 20.2%. Academic centers were nearly three times more likely to use guideline-based chemotherapy protocols. And community hospitals provided HIPEC to only 10.4% of eligible patients, compared to 28.8% at academic centers.
Why Financial Help Is a Medical Tool
In mesothelioma care, the uncomfortable truth is this: people with more financial resources tend to live longer. That's because they can access more options. And in cancer treatment, options are everything.
More financial support means:
Second opinions from top cancer centers instead of settling for local facilities with limited mesothelioma experience
Access to immunotherapy or clinical trials that insurance won't always cover
Travel to specialists who treat hundreds of mesothelioma cases a year, not just a handful
Staying near a treatment center during intensive therapy instead of commuting for hours while exhausted
Hiring home help so your spouse and children don't have to become full-time caregivers
Covering the out-of-pocket accumulation — transportation, medications, lost income, and the gaps insurance doesn't fill
When we say money is an important part of treatment, we're not being dramatic. We're being accurate. Compensation from asbestos claims changes the range of what a patient can say yes to. It funds the second opinion that changes a treatment plan. It pays for the HIPEC procedure insurance denied. It gives a doctor more options.
You are not taking anything you didn't already pay for. You paid for it in your lungs, your health, and your time.
The asbestos companies made a calculated business decision: to protect their profits, knowing what their product did to people. Now it's your turn to make a calculated decision to do what is best for your family. That means doing whatever is necessary to access the best care available.
Common Hesitations About Seeking Help
Even when the need is obvious, many people hesitate because something tells them they just shouldn't ask. These are the most common doubts we hear, and the truth behind each one.
"I don't want to sue anyone."
Most mesothelioma claims never involve a public courtroom. Many of the companies responsible went bankrupt decades ago and were required to fund asbestos trusts. Those are pools of money set aside specifically to compensate the people they harmed. Claims against these trusts are handled on paper, not in courtrooms. That means no depositions, no trials, and no dragging your name through the legal system.
For cases involving companies still in business, the vast majority settle quietly and quickly before trial.
Most asbestos companies carried insurance policies to protect them from the consequences of their own decisions. If you wouldn't hesitate to pursue a drunk driver's insurance policy, you shouldn't hesitate here either.
"Other people have it worse than me."
That was Clarence Borel's thinking, too. He was a Texas insulation worker who filed the first mesothelioma lawsuit — not for personal gain, but because he understood that the evidence in his case could protect other workers. He agreed to go forward only when he realized his lawsuit might change the system to protect others. And it did. Clarence's case is why people in your position have legal rights today. Pursuing those rights protects your family and it honors the work he did.
"I waited too long."
Maybe you didn't file right after diagnosis. Maybe your exposure happened 40 years ago at a job site that no longer exists. That's entirely normal in mesothelioma cases. We have helped clients file claims 50 or more years after their exposure, and in many cases, families can still file after a loved one has passed. Don't assume it's too late — ask.
That said, every state does impose filing deadlines for mesothelioma claims, and the laws governing them are complex. Call us at 833-4-ASBESTOS for a frank answer about how much time you and your family have.
"It feels wrong to ask for money because I got sick."
It's not wrong. What's wrong is that companies knew asbestos caused cancer and kept using it anyway while people like you were working hard, serving their country, or simply earning a living.
This isn't about a windfall or "jackpot justice." It's about leveling a playing field that was tilted against you before you ever showed up for work. The compensation exists because the harm was real, documented, and preventable. You're not taking anything you're not owed.
Sources of Financial Support
You may have more help available than you realize. Multiple systems have been built specifically for people affected by mesothelioma.
Asbestos Trust Funds
Many asbestos manufacturers filed for bankruptcy decades ago and were required to fund asbestos trusts, which are pools of money set aside to compensate people harmed by their products. These trusts were funded with more than $30 billion dollars. You don't need to file a lawsuit or appear in court to get a settlement from these trusts. If you qualify, the process is handled on paper and claims are often paid within months. We handle the entire filing.
Learn more about asbestos trust claims
Lawsuits Against Active Companies
Some asbestos companies are still in business and therefore still legally responsible for the harm they caused. If your exposure involved one of these companies, a lawsuit may be appropriate. Most cases settle before trial. You don't need to be in perfect health to file, and acting promptly typically increases the value of a case.
Learn more about mesothelioma lawsuits
Social Security Disability (SSDI)
Mesothelioma qualifies for the Social Security Administration's Compassionate Allowances program, which fast-tracks disability benefit approval. For patients who have worked enough quarters to qualify, benefits can be approved in weeks rather than months — and approval also accelerates Medicare eligibility. That matters when treatment costs are accumulating and insurance gaps are growing.
Learn more about SSDI for mesothelioma
VA Benefits for Veterans
Veterans exposed to asbestos during military service are frequently eligible for monthly disability compensation and full VA healthcare coverage. Mesothelioma disability ratings are typically 100%, qualifying veterans for the maximum compensation rate. VA benefits can be pursued alongside trust fund claims and lawsuits without affecting eligibility for either. That's because they are entirely separate systems with separate funding.
Learn more about VA benefits for mesothelioma
Immunotherapy and Drug Copay Assistance
For high-cost treatments like immunotherapy, many drug manufacturers offer copay relief programs or free medication for uninsured and underinsured patients. We help clients navigate these programs so that cost doesn't stand between them and the best available care.
Travel and Lodging Support
The best mesothelioma specialists are concentrated at a small number of centers across the country. Getting there takes planning and money. Our firm advances the costs of travel, lodging, and extended stays near top cancer centers. They're repaid from your eventual recovery, not out of your pocket. We also connect clients with nonprofit medical travel programs where appropriate, and make sure every travel expense is properly documented and included in any claim or settlement.
Our job is to unlock every possible source of help and walk through it with you, step by step.
NCI-Designated Cancer Centers: A Complete Directory
When our clients need the best possible care, we direct them to NCI-designated cancer centers. The National Cancer Institute designates only those institutions that meet the highest federal standards for cancer research, patient care, and clinical infrastructure.
Comprehensive Cancer Centers must demonstrate excellence across laboratory research, clinical research, and community outreach. They offer the widest range of active clinical trials, the most advanced available therapies, and multidisciplinary care teams specifically equipped for a rare cancer like mesothelioma.
Clinical Cancer Centers focus primarily on patient care and clinical research. They meet rigorous NCI standards, often have strong regional connections, and may have shorter wait times, while maintaining the same commitment to quality.
Both types represent the standard we want for every mesothelioma patient. With legal compensation, distance to any of them doesn't have to be a barrier.
State | Cancer Center | Location | Type |
|---|---|---|---|
Alabama | O'Neal Comprehensive Cancer Center | Birmingham | Comprehensive |
Arizona | University of Arizona Cancer Center | Tucson | Comprehensive |
Arizona | Mayo Clinic Cancer Center | Phoenix | Comprehensive |
California | Chao Family Comprehensive Cancer Center | Orange | Comprehensive |
California | Stanford Cancer Institute | Stanford | Comprehensive |
California | City of Hope Comprehensive Cancer Center | Duarte | Comprehensive |
California | UC Davis Comprehensive Cancer Center | Sacramento | Comprehensive |
California | Jonsson Comprehensive Cancer Center (UCLA) | Los Angeles | Comprehensive |
California | Moores Comprehensive Cancer Center (UCSD) | La Jolla | Comprehensive |
California | UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | Comprehensive |
California | USC Norris Comprehensive Cancer Center | Los Angeles | Comprehensive |
Colorado | University of Colorado Cancer Center | Aurora | Comprehensive |
Connecticut | Yale Cancer Center | New Haven | Comprehensive |
DC | Georgetown Lombardi Comprehensive Cancer Center | Washington | Comprehensive |
Florida | Mayo Clinic Cancer Center | Jacksonville | Comprehensive |
Florida | Moffitt Cancer Center | Tampa | Comprehensive |
Florida | Sylvester Comprehensive Cancer Center | Miami | Clinical |
Florida | University of Florida Health Cancer Center | Gainesville | Clinical |
Georgia | Winship Cancer Institute (Emory) | Atlanta | Comprehensive |
Hawaii | University of Hawaii Cancer Center | Honolulu | Clinical |
Illinois | Robert H. Lurie Comprehensive Cancer Center (Northwestern) | Chicago | Comprehensive |
Illinois | University of Chicago Comprehensive Cancer Center | Chicago | Comprehensive |
Indiana | Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Comprehensive |
Iowa | Holden Comprehensive Cancer Center | Iowa City | Comprehensive |
Kansas | University of Kansas Cancer Center | Kansas City | Comprehensive |
Kentucky | Markey Cancer Center | Lexington | Comprehensive |
Maryland | Sidney Kimmel Comprehensive Cancer Center (Johns Hopkins) | Baltimore | Comprehensive |
Maryland | University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore | Comprehensive |
Massachusetts | Dana-Farber/Harvard Cancer Center | Boston | Comprehensive |
Michigan | Barbara Ann Karmanos Cancer Institute | Detroit | Comprehensive |
Michigan | University of Michigan Rogel Cancer Center | Ann Arbor | Comprehensive |
Minnesota | Masonic Cancer Center | Minneapolis | Comprehensive |
Minnesota | Mayo Clinic Cancer Center | Rochester | Comprehensive |
Missouri | Alvin J. Siteman Cancer Center | St. Louis | Comprehensive |
Nebraska | Fred and Pamela Buffett Cancer Center | Omaha | Clinical |
New Hampshire | Dartmouth Cancer Center | Lebanon | Comprehensive |
New Jersey | Rutgers Cancer Institute of New Jersey | New Brunswick | Comprehensive |
New Mexico | University of New Mexico Cancer Research and Treatment Center | Albuquerque | Comprehensive |
New York | Montefiore Einstein Cancer Center | Bronx | Comprehensive |
New York | Memorial Sloan Kettering Cancer Center | New York | Comprehensive |
New York | Roswell Park Comprehensive Cancer Center | Buffalo | Comprehensive |
New York | Herbert Irving Comprehensive Cancer Center (Columbia) | New York | Comprehensive |
New York | Tisch Cancer Institute (Mount Sinai) | New York | Clinical |
New York | Laura and Isaac Perlmutter Cancer Center (NYU) | New York | Comprehensive |
New York | Wilmot Cancer Institute | Rochester | Clinical |
North Carolina | Duke Cancer Institute | Durham | Comprehensive |
North Carolina | Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | Comprehensive |
North Carolina | UNC Lineberger Comprehensive Cancer Center | Chapel Hill | Comprehensive |
Ohio | Case Comprehensive Cancer Center | Cleveland | Comprehensive |
Ohio | Ohio State University Comprehensive Cancer Center | Columbus | Comprehensive |
Oklahoma | Stephenson Cancer Center | Oklahoma City | Clinical |
Oregon | Knight Cancer Institute | Portland | Comprehensive |
Pennsylvania | Abramson Cancer Center (University of Pennsylvania) | Philadelphia | Comprehensive |
Pennsylvania | UPMC Hillman Cancer Center | Pittsburgh | Comprehensive |
Pennsylvania | Fox Chase Cancer Center | Philadelphia | Comprehensive |
Pennsylvania | Sidney Kimmel Cancer Center (Thomas Jefferson) | Philadelphia | Comprehensive |
South Carolina | Hollings Cancer Center | Charleston | Clinical |
Tennessee | St. Jude Children's Research Hospital | Memphis | Comprehensive |
Tennessee | Vanderbilt-Ingram Cancer Center | Nashville | Comprehensive |
Texas | Dan L Duncan Comprehensive Cancer Center (Baylor) | Houston | Comprehensive |
Texas | Mays Cancer Center (UT Health San Antonio) | San Antonio | Clinical |
Texas | Harold C. Simmons Comprehensive Cancer Center (UT Southwestern) | Dallas | Comprehensive |
Texas | MD Anderson Cancer Center | Houston | Comprehensive |
Utah | Huntsman Cancer Institute | Salt Lake City | Comprehensive |
Virginia | VCU Massey Comprehensive Cancer Center | Richmond | Comprehensive |
Virginia | University of Virginia Cancer Center | Charlottesville | Comprehensive |
Washington | Fred Hutchinson/University of Washington Cancer Consortium | Seattle | Comprehensive |
Wisconsin | University of Wisconsin Carbone Cancer Center | Madison | Comprehensive |
If you need help getting to the right treatment center, call us today at 833-4-ASBESTOS.
Why Families Come to Us
We know you have choices. We also know you never imagined needing a mesothelioma attorney. Families come to us for a reason: we make this process as honest, thorough, and human as it can be.
We understand this disease personally. Our founding attorney lost his father, grandfather, and grandmother to asbestos-related cancers. He's been in the waiting rooms and had the hard conversations. That experience shaped everything about how this firm operates. This isn't just legal work for us.
We handle the evidence. You don't need to track down job records from 1975 or contact former employers. We work with medical experts, investigators, and industrial historians to reconstruct exposure timelines going back decades, using our proprietary database of more than 200,000 verified exposure sites and millions of pages of company records, medical studies, and court documents.
We front all costs. We advance filing fees, expert fees, and travel expenses. You owe us nothing unless we recover money for you. We have recovered more than $400 million for people with asbestos-related diseases since 2014.
We work nationwide. Whether your exposure happened in a refinery in Texas, a Navy ship in San Diego, or a steel plant in Ohio, we can help. Our offices are in California, Washington, Texas, and Arizona — and we serve clients across the country through video meetings or in-person visits anywhere in the U.S.
A Path Forward for Your Family
You've already taken the hardest step: facing the reality of this diagnosis. The next step is finding out what help is available.
Call us today at 833-4-ASBESTOS (833-427-2378) or fill out the form for a free, confidential consultation. No cost. No pressure. No obligation. No fee unless we recover money for you.
You didn't choose this diagnosis. But you can choose what happens next. And you don't have to face it alone.
References
Welten, V. M., Fields, A. C., Malizia, R. A., Yoo, J., Irani, J. L., Goldberg, J. E., Bleday, R., & Melnitchouk, N. (2022). Survival outcomes for malignant peritoneal mesothelioma at academic versus community hospitals. Journal of Gastrointestinal Surgery, 26(1), 161–170. https://doi.org/10.1007/s11605-021-05084-0
Verma, V., Ahern, C. A., Berlind, C. G., Lindsay, W. D., Grover, S., Culligan, M. J., Friedberg, J. S., & Simone, C. B. (2018). Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis. Lung Cancer, 120, 7–13. https://doi.org/10.1016/j.lungcan.2018.03.019
National Cancer Institute. (2025). Find an NCI-designated cancer center. https://www.cancer.gov/research/infrastructure/cancer-centers/find